Natera, Inc.

  • Moat Score
  • Safety Score
  • Market Cap $19.35B
  • PE -102
  • Debt $80.36M
  • Cash $945.59M
  • EV $18.49B
  • FCF $69.24M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings-$190.43M
EBIT-$189.73M
ROE-16%
ROA-11%
FCF$69.24M
Equity$1.20B
Growth Stability1
PE-101.63
PB16.19
P/FCF279.51
P/S11.41
Price/Cash0.05
Debt/Equity0.07
Debt/FCF1.16
Net Margins-11%
Op. Margins-11%
Sales Growth YoY53%
Sales Growth QoQ8%
Sales CAGR30%
Equity CAGR33%
Earnings Growth YoY-31%
Earnings Growth QoQ70%
Sales CAGR 5Y40%
Equity CAGR 5Y26%
Earnings CAGR 3Y39%
Sales CAGR 3Y39%
Equity CAGR 3Y36%
Market Cap$19.35B
Revenue$1.70B
Assets$1.66B
Total Debt$80.36M
Cash$945.59M
Shares Outstanding124.46M
EV18.49B
Moat Score5%
Safety Score96%
Working Capital1.03B
Current Ratio4
Shares Growth 3y12%
Equity Growth QoQ36%
Equity Growth YoY56%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
Natera Inc is operative in the healthcare field in the United States. Its core business is to offer invasive and other means of diagnosing the genetic features of a fetus. Natera's array of diagnostic services includes Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, Anora Products of Conception (POC) test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing (PAT), to determine paternity by studying the fragments of fetal deoxyribonucleic acid (DNA) in a pregnant mother's blood and a blood sample from the alleged father. The Company acquires its revenue by billing an insurance carrier, a clinic, or a patient for the test upon delivery of the test result.

SEC Filings

Direct access to Natera, Inc. (NTRA) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Natera, Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Natera, Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

loading chart...

Natera, Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Natera, Inc..

= $692M
012345678910TV
fcf$69M$69M$69M$69M$69M$69M$69M$69M$69M$69M$69M$692M
DCF$63M$57M$52M$47M$43M$39M$36M$32M$29M$27M$267M
Value$692M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024TTM
Net Margins-37%-44%-65%-50%-41%-59%-75%-67%-40%-11%-11%
ROA--45%-75%-43%-20%-23%-38%-39%-30%-11%-11%
ROE--90%1K%-398%-45%-47%-72%-78%-57%-16%-16%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024TTM
Debt over FCF--0.51-1.15-1.66-1.83-1.25-0.9-0.77-1.291.161.16
Debt over Equity0.230.47-11.883.840.450.520.520.520.480.070.07
Growth Stability----------1

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024CAGR 5Y
Revenue YoY growth-14%-3%22%17%29%60%31%32%57%40%
Earnings YoY growth-36%42%-6%-3%84%105%16%-21%-56%-
Equity YoY growth--42%-110%-410%767%74%34%8%8%56%26%
FCF YoY growth-112%10%-30%-8%195%86%27%-40%-124%-